- £34.92m
- -£2.08m
- £49.90m
- 90
- 72
- 22
- 68
R2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.9 | 29 | 28.1 | 34.5 | 49.9 |
Cost of Revenue | |||||
Gross Profit | 21.5 | 28.6 | 27.6 | 33.9 | 48.2 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 19.7 | 18.7 | 20.3 | 24.1 | 41.8 |
Operating Profit | 2.25 | 10.3 | 7.8 | 10.4 | 8.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2.14 | 10.2 | 7.4 | 10 | 7.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.14 | 8.09 | 5.9 | 7.4 | 5.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.14 | 8.09 | 5.9 | 7.4 | 5.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.14 | 8.09 | 5.9 | 7.4 | 5.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.097 | 0.087 | 0.057 | 0.068 | 0.045 |
Dividends per Share |